Amino acids play a crucial role in metabolism, being classified as both glucogenic and ketogenic. While all amino acids contribute to the generation of urea, none can directly interact with complex II of the electron transport chain; this function is specifically performed by FAD. In the liver mitochondria, the degradation of amino acids begins with transamination, where glutamate is converted to α-ketoglutarate through oxidative deamination.
Glucogenic amino acids, such as serine, cysteine, and alanine, are catabolized to produce pyruvate, which can then enter gluconeogenesis or the citric acid cycle. A notable genetic disorder related to amino acid metabolism is phenylketonuria (PKU), which arises from a defect in the enzyme responsible for converting phenylalanine to tyrosine. This metabolic block leads to the accumulation of phenylalanine and its byproducts, such as phenylacetate, which serve as markers for the condition. Newborns are routinely screened for these compounds to identify PKU early, allowing for dietary interventions that limit phenylalanine intake during critical periods of brain development.
